COMMUNIQUÉS West-GlobeNewswire

-
Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical’s QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024 - Update
25/10/2024 -
Autonomix Medical, Inc. to Participate in a Virtual Investor “What This Means” Segment on Wednesday, October 30th
25/10/2024 -
Ultimovacs Announces Publication of Phase II FOCUS Trial Results on medRxiv
25/10/2024 -
Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, Announces Recruitment of Second Clinical Trial Site for Ongoing Phase IIb Clinical Trial of Nature-Derived Psilocybin for Adjustment Disorder in Palliative Care
25/10/2024 -
Aeroflow Health Leads the Way in Asheville and Western NC Aid and Recovery Efforts
25/10/2024 -
Trinity Biotech Enters Oncology Space with Acquisition of Prostate Cancer Focused EpiCapture
25/10/2024 -
Trinity Biotech Announces Strategic Investment in Novus Diagnostics to Advance Rapid Sepsis Testing Platform
25/10/2024 -
Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference
25/10/2024 -
Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical’s QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024
25/10/2024 -
Celldex Announces Upcoming Late Breaking Oral Presentation of 12 Week Results from Barzolvolimab Phase 2 Study in Chronic Inducible Urticaria at ACAAI 2024
25/10/2024 -
Alvotech Meeting Investors and Presenting at the Jefferies 2024 London Healthcare Conference on November 19–20, 2024
25/10/2024 -
Tonix Pharmaceuticals to Present at the 2024 ThinkEquity Conference
25/10/2024 -
Alvotech Meeting Investors and Presenting at the Jefferies 2024 London Healthcare Conference on November 19–20, 2024
25/10/2024 -
Acasti Announces Corporate Name Change to Grace Therapeutics, Inc.
25/10/2024 -
Apyx Medical Corporation to Release Third Quarter Of Fiscal Year 2024 Financial Results on November 8, 2024
25/10/2024 -
Senseonics Holdings, Inc. Announces $16 Million Registered Direct Offering
25/10/2024 -
Rakovina Therapeutics to Present Research Highlighting Small-Molecule Bifunctional Inhibitors of PARP1/2 and HDAC Enzymes at the 36th EORTC-NCI-AACR Symposium in Barcelona Spain
25/10/2024 -
Y-mAbs Announces Third Quarter 2024 Conference Call and Webcast
25/10/2024 -
FosterVA Shares the Shortfall of Insights in Foster Care and Child Welfare Trends: Advocates Call for Contextual Data to Improve Outcomes for Children and Families
25/10/2024
Pages